Information Provided By:
Fly News Breaks for March 11, 2016
ACUR
Mar 11, 2016 | 07:39 EDT
Roth Capital analyst Michael Higgins re-initiated shares of Acura Pharmaceuticals with a Buy rating and $6 price target.
News For ACUR From the Last 2 Days
There are no results for your query ACUR